ABOUT TMUNITY THERAPEUTICS
Tmunity Therapeutics is a private biotherapeutics company focused on saving and improving lives by delivering the full potential of next-generation T cell immunotherapy to more patients with devastating diseases.
Integrating broad collaborations with the University of Pennsylvania (UPenn) and the University of Minnesota with the groundbreaking scientific, clinical and manufacturing expertise and demonstrated track record of its founders, Tmunity is developing personalized immunotherapies for cancer, infectious disease and autoimmune disease that are advancing rapidly toward the clinic. With headquarters in Philadelphia, Tmunity utilizes laboratories and production facilities at UPenn and its own dedicated cGMP manufacturing facility in Norristown, PA, to pursue process improvement and production scale-up in support of clinical development of T cell therapies.
“Extraordinary advances have already been made with the development of the first generation of cell-based immunotherapies for cancer. We formed Tmunity, bringing together all the essential expertise, technology and scientific insight, to make the next great leap, to deliver the full promise of T cell medicine to patients.”
Carl H. June, MD